Seroprevalence of Hepatitis A Virus in Pediatric Patients with Hematologic Malignancies after Chemotherapy and Hematopoietic Cell Transplantation
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
This retrospective study was performed to determine the seroprevalence of hepatitis A virus (HAV) in children and adolescents with hematologic malignancies after the completion of chemotherapy and hematopoietic cell transplantation (HCT). Of 97 enrolled patients, 60 (61.9%) were seropositive for HAV. The seroprevalences in patients undergoing chemotherapy and HCT were 60.3% (41/68) and 65.5% (19/29), respectively (P = 0.628). No significant factors associated with seropositivity for HAV after chemotherapy and HCT were identified. Anti-HAV tests and HAV re-vaccinations can be considered in children and adolescents with underlying hematologic malignancies after chemotherapy and HCT based on the anti-HAV results.
Abstract
This retrospective study was performed to determine the seroprevalence of hepatitis A virus (HAV) in children and adolescents with hematologic malignancies after the completion of chemotherapy and hematopoietic cell transplantation (HCT). Of 97 enrolled patients, 60 (61.9%) were seropositive for HAV. The seroprevalences in patients undergoing chemotherapy and HCT were 60.3% (41/68) and 65.5% (19/29), respectively (P = 0.628). No significant factors associated with seropositivity for HAV after chemotherapy and HCT were identified. Anti-HAV tests and HAV re-vaccinations can be considered in children and adolescents with underlying hematologic malignancies after chemotherapy and HCT based on the anti-HAV results.
참고문헌 (14)
- Hunger SP, "Acute lymphoblastic leukemia in children", N Engl J Med, 373, pp.1541~1552 (2015)
- Rubnitz JE, "Current management of childhood acute myeloid leukemia", Paediatr Drugs, 19, pp.1~10 (2017)
- Rubin LG, "2013 IDSA clinical practice guideline for vaccination of the immunocompromised host", Clin Infect Dis, 58, pp.e44~e100 (2014)
- Alanko S, "Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia", Cancer, 69, pp.1481~1486 (1992)
- Godoi ER, "Loss of hepatitis A virus antibodies after bone marrow transplantation", Bone Marrow Transplant, 38, pp.37~40 (2006)
- Unal Ince E, "Significant loss of hepatitis A Ab after allogeneic hematopoietic SCT in pediatric patients", Bone Marrow Transplant, 45, pp.171~175 (2010)
- Yalçin SS, "Naturally acquired hepatitis A antibodies after haematopoetic stem cell transplantation", Epidemiol Infect, 139, pp.683~687 (2011)
- Köksal Y, "Immunogenicity of hepatitis a vaccine in children with cancer", Pediatr Hematol Oncol, 23, pp.619~624 (2006)
- Patel SR, "Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation", Clin Infect Dis, 44, pp.625~634 (2007)
- Patel SR, "Revaccination of children after completion of standard chemotherapy for acute leukemia", Clin Infect Dis, 44, pp.635~642 (2007)
- "Infectious diseases surveillance yearbook" (2017)[URL]
- Yoon EL, "Current status and strategies for the control of viral hepatitis A in Korea", Clin Mol Hepatol, 23, pp.196~204 (2017)
- Carpenter PA, "How I vaccinate blood and marrow transplant recipients", Blood, 127, pp.2824~2832 (2016)
- Yang HI, "National immunization survey in South Korea, 2013", Public Health Wkly Rep, 7, pp.449~454 (2014)